The Europe Glucosamine Market would witness market growth of 4.8% CAGR during the forecast period (2023-2030). In the year 2020, the Europe market's volume surged to 9,750.41 Tonnes, showcasing a growth of 4.0% (2019-2022).
The rise of e-commerce platforms has played a pivotal role in adopting glucosamine. Consumers can easily access various products online, providing unparalleled convenience. This accessibility has contributed to the compound's adoption, transcending geographical boundaries and making it available to a diverse consumer base. E-commerce platforms also facilitate a diverse range of products, allowing consumers to choose from various formulations, concentrations, and brands. This product diversity caters to different preferences and health needs, further fuelling the adoption of this among consumers with specific requirements.
Adopting plant-based glucosamine alternatives has gained momentum, particularly among individuals with dietary restrictions or ethical considerations. As more plant-derived sources become available, the market expands, welcoming new adopters whom traditional shellfish-derived products have deterred. The trend towards personalized nutrition has led to the development of customized formulations. Companies increasingly offer these supplements and other ingredients tailored to address specific health concerns, providing consumers with personalized solutions, and further enhancing adoption rates.
The aging population is increasingly adopting preventive healthcare measures to maintain overall health in Europe. Aging individuals are more conscious of their health and wellness, seeking holistic solutions to maintain an active lifestyle in Europe. With aging comes an increased prevalence of joint disorders in Europe, such as osteoarthritis and joint stiffness. The aging population in Europe is becoming more health-conscious, seeking preventive measures to maintain overall well-being. Similarly, according to a report on the French aging policy published by the UN, as in other European countries, France faces a continuous and significant increase in the number of older people. The nation had 15 million people aged more than 60 in France in 2012, expected to reach 24 million in 2060. Hence, all these factors will uplift the regional market’s expansion in the coming years.
The Germany market dominated the Europe Glucosamine Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $57 Million by 2030. The UK market is exhibiting a CAGR of 3.8% during (2023 - 2030). Additionally, The France market would experience a CAGR of 5.6% during (2023 - 2030).
Based on Application, the market is segmented into Supplement, Food & Beverage, and Others. Based on Product, the market is segmented into Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The rise of e-commerce platforms has played a pivotal role in adopting glucosamine. Consumers can easily access various products online, providing unparalleled convenience. This accessibility has contributed to the compound's adoption, transcending geographical boundaries and making it available to a diverse consumer base. E-commerce platforms also facilitate a diverse range of products, allowing consumers to choose from various formulations, concentrations, and brands. This product diversity caters to different preferences and health needs, further fuelling the adoption of this among consumers with specific requirements.
Adopting plant-based glucosamine alternatives has gained momentum, particularly among individuals with dietary restrictions or ethical considerations. As more plant-derived sources become available, the market expands, welcoming new adopters whom traditional shellfish-derived products have deterred. The trend towards personalized nutrition has led to the development of customized formulations. Companies increasingly offer these supplements and other ingredients tailored to address specific health concerns, providing consumers with personalized solutions, and further enhancing adoption rates.
The aging population is increasingly adopting preventive healthcare measures to maintain overall health in Europe. Aging individuals are more conscious of their health and wellness, seeking holistic solutions to maintain an active lifestyle in Europe. With aging comes an increased prevalence of joint disorders in Europe, such as osteoarthritis and joint stiffness. The aging population in Europe is becoming more health-conscious, seeking preventive measures to maintain overall well-being. Similarly, according to a report on the French aging policy published by the UN, as in other European countries, France faces a continuous and significant increase in the number of older people. The nation had 15 million people aged more than 60 in France in 2012, expected to reach 24 million in 2060. Hence, all these factors will uplift the regional market’s expansion in the coming years.
The Germany market dominated the Europe Glucosamine Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $57 Million by 2030. The UK market is exhibiting a CAGR of 3.8% during (2023 - 2030). Additionally, The France market would experience a CAGR of 5.6% during (2023 - 2030).
Based on Application, the market is segmented into Supplement, Food & Beverage, and Others. Based on Product, the market is segmented into Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Teva Pharmaceutical Industries Ltd.
- Laboratoires Expanscience S.A.
- Nutramax Laboratories, Inc.
- Amway Corporation
- CellMark AB
- Alfa Chemical Group
- Cargill, Incorporated
- Simply Supplements
- Reckitt Benckiser Group PLC
- Panvo Organics Pvt Ltd.
Market Report Segmentation
By Application (Volume, Tonnes, USD Billion, 2019-2030)- Supplement
- Food & Beverage
- Others
- Glucosamine Sulfate
- Glucosamine Hydrochloride
- N-acetyl Glucosamine
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Glucosamine Market by Application
Chapter 5. Europe Glucosamine Market by Product
Chapter 6. Europe Glucosamine Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Teva Pharmaceutical Industries Ltd.
- Laboratoires Expanscience S.A.
- Nutramax Laboratories, Inc.
- Amway Corporation
- CellMark AB
- Alfa Chemical Group
- Cargill, Incorporated
- Simply Supplements
- Reckitt Benckiser Group PLC
- Panvo Organics Pvt Ltd.
Methodology
LOADING...
